NATICK, Mass., Oct. 14, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) welcomes yesterday's introduction of the Medical Device Regulatory Improvement Act, sponsored by Sen. Amy Klobuchar (D-MN) and cosponsored by Sens. Richard Burr (R-NC) and Michael Bennet (D-CO). The legislation is intended to streamline the medical device review and approval process, reduce regulatory delays and help new medical technologies safely and more expeditiously reach patients.
Boston Scientific commends Senators Klobuchar, Burr and Bennet for their thoughtful leadership in introducing this new legislation designed to streamline the Food and Drug Administration's regulation of medical devices. This bill is an important step in transforming the process of bringing life-enhancing and life-saving medical technologies to market in a safe and more efficient and predictable manner.
Boston Scientific looks forward to collaborating with the sponsoring senators and other Members of Congress on this important piece of legislation.
About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com. CONTACT:
Erik Kopp508-650-8660 (office)Media RelationsBoston Scientific Corporationerik.email@example.comSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific Corporationinvestor_relations@bsci.com
|SOURCE Boston Scientific Corporation|
Copyright©2010 PR Newswire.
All rights reserved